[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hirudin Market Survey and Trend Research 2018

January 2018 | 87 pages | ID: G39727D7694EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Hirudin isA naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that hasA blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makesA scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (The Medicines Company, Keyken, Minapharm, Abbott, Pfizer, Inc, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, DUOPUTAI, Pentapharm etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Hirudin Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 HIRUDIN MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 The Medicines Company (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Keyken (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Minapharm (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Abbott (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Pfizer, Inc (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Pfizer, Inc (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Teva Pharmaceutical Industries Ltd (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 DUOPUTAI (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Pentapharm (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table GLOBAL HIRUDIN MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Hirudin Market 2012-2017, by Type, in Volume
Table Global Hirudin Market Forecast 2018-2023, by Type, in USD Million
Table Global Hirudin Market Forecast 2018-2023, by Type, in Volume
Table The Medicines Company Overview List
Table Hirudin Business Operation of The Medicines Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Keyken Overview List
Table Hirudin Business Operation of Keyken (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Minapharm Overview List
Table Hirudin Business Operation of Minapharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Overview List
Table Hirudin Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc Overview List
Table Hirudin Business Operation of Pfizer, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc Overview List
Table Hirudin Business Operation of Pfizer, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Overview List
Table Hirudin Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DUOPUTAI Overview List
Table Hirudin Business Operation of DUOPUTAI (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pentapharm Overview List
Table Hirudin Business Operation of Pentapharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Hirudin Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Hirudin Sales Revenue Share, by Companies, in USD Million
Table Global Hirudin Sales Volume 2012-2017, by Companies, in Volume
Table Global Hirudin Sales Revenue Share, by Companies in 2017, in Volume
Table Hirudin Demand 2012-2017, by Application, in USD Million
Table Hirudin Demand 2012-2017, by Application, in Volume
Table Hirudin Demand Forecast 2018-2023, by Application, in USD Million
Table Hirudin Demand Forecast 2018-2023, by Application, in Volume
Table Global Hirudin Market 2012-2017, by Region, in USD Million
Table Global Hirudin Market 2012-2017, by Region, in Volume
Table Hirudin Market Forecast 2018-2023, by Region, in USD Million
Table Hirudin Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Hirudin Industry Chain Structure
Figure Global Hirudin Market Growth 2012-2017, by Type, in USD Million
Figure Global Hirudin Market Growth 2012-2017, by Type, in Volume
Figure Global Hirudin Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Hirudin Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications